Arbutus Biopharma Corp
ABUS | NASDAQ
$5
-$0.01 (-0.20%)
At close: Sep 21, 2026, 4:00 PM ET
$5.03
+$0.03 (+0.54%)
After-hours:
Sep 21, 2026, 7:53 PM ET
Institutional Ownership
Net InflowTotal Institutions
175
Total Ownership
71.73%
Capital Flow
+$38.51M
Shares Change
+16.96M
Ownership Distribution
Institutions (71.73%)
Others (28.27%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
29
Increased Positions
76
Reduced Positions
50
Closed Positions
37
New (29)
Increased (76)
Reduced (50)
Closed (37)
Options Sentiment & Activity
neutralPut/Call Ratio
1.090
Call Flow
470,300
Put Flow
512,400
Calls (48%)
Puts (52%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Gotham Asset Management LLC | < 0.01% 0.00% | < 0.01% | 17.32K | 79.33K |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Morgan Stanley | 13.36% -4.12% | < 0.01% -8.46% | 25.89M -3.04% | 116.51M -9.29% | |
| Two Seas Capital LP | 9.58% +45.76% | 1.17% -6.45% | 18.56M +47.41% | 83.51M +37.91% | |
| Whitefort Capital Management, LP | 7.71% +10.65% | 19.81% +20.77% | 14.93M +11.90% | 67.19M +4.69% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove ABUS